# Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia

> **NCT01027624** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3000 (estimated)

## Conditions studied

- Undertreatment of Hypercholesterolaemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01027624
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2011-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01027624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01027624, "Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01027624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*